The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints

The complete blood count (CBC) and basic metabolic profile are common, low‐cost blood tests, which have previously been used to create and validate the Intermountain Risk Score (IMRS) for mortality prediction. Mortality is the most definitive clinical endpoint, but medical care is more easily applied to modify morbidity and thereby prevent death. This study tested whether IMRS is associated with clinical morbidity endpoints.